Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently From Rai Staging or Cytogenetics

Ryan A. Wilcox, MD, PhD, Kari Rabe, MS, Neil Kay, MD, Timothy G. Call, MD, Svetomir N. Markovic, MD, PhD, Luis F. Porrata, MD, Susan Schwager, Clive S. Zent, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 2835.

https://doi.org/10.1182/blood.V118.21.2835.2835

Published: 2011

Journal Articles

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Susan L Slager, PhD, Mark C Lanasa, MD, PhD, Sallie D. Allgood, MS, Sara J Achenbach, Aaron Norman, MS, Celine M Vachon, PhD, Lynn Goldin, PhD, Jose F. Leis, MD, PhD, Neil Kay, MD, J. Brice Weinberg, MD, Kari Rabe, MS, Timothy G. Call, MD, James R Cerhan, MD, PhD, Tait D. Shanafelt, MD, Neil E Caporaso, MD, Gerald E Marti, MD, PhD, Curtis A. Hanson, MD

Blood (2011) 118 (21): 3881.

https://doi.org/10.1182/blood.V118.21.3881.3881

Published: 2011

Journal Articles

Infectious Complications Among Individuals with Monoclonal B-Cell Lymphocytosis (MBL): A Prospective Case-Control Study of Newly Diagnosed Patients,

Jonathan Moreira, MD, Kari Rabe, MS, James R Cerhan, MD, PhD, Curtis A. Hanson, MD, Timothy G Call, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Deborah A. Bowen, John Wilson, MD, Neil Kay, MD, Susan Schwager, Randy F Wendt, Susan L Slager, PhD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 3903.

https://doi.org/10.1182/blood.V118.21.3903.3903

Published: 2011

Journal Articles

The Prevalence of Serious Infectious Complications in a Cohort of Non-Referred Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

Jonathan Moreira, MD, Kari Rabe, MS, James R Cerhan, MD, PhD, John Wilson, MD, Neil Kay, MD, Clive S. Zent, MD, Deborah Bowen, Jose F. Leis, MD, PhD, Susan L Slager, PhD, Susan Schwager, Randy F Wendt, Timothy G Call, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 4610.

https://doi.org/10.1182/blood.V118.21.4610.4610

Published: 2011

Journal Articles

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

Wei Ding, MD, PhD, Tait D. Shanafelt, MD, Kari Rabe, MS, Timothy G. Call, MD, Clive S. Zent, MD, Neil Kay, MD, David James Inwards, MD, Deborah Bowen, Mark R. Litzow, MD, Susan L Slager, PhD, Susan Schwager, William J Hogan, MBBCh

Blood (2011) 118 (21): 4152.

https://doi.org/10.1182/blood.V118.21.4152.4152

Published: 2011

Journal Articles

CD5+ Chronic B-Cell Lymphoproliferative Disorders Could Contain a Novel Disease Entity.

Roxana S Dronca, MD, Curtis A. Hanson, MD, Dragan Jevremovic, MD, PhD, C. Scott Collins, MD, Kari Rabe, MS, Jessica Sonbert, Susan L. Slager, PhD, Susan Schwager, Tait D. Shanafelt, MD, Neil E. Kay, MD, Clive S. Zent, MD

Blood (2008) 112 (11): 2065.

https://doi.org/10.1182/blood.V112.11.2065.2065

Published: 2008

NARROW

In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently From Rai Staging or Cytogenetics

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Infectious Complications Among Individuals with Monoclonal B-Cell Lymphocytosis (MBL): A Prospective Case-Control Study of Newly Diagnosed Patients,

The Prevalence of Serious Infectious Complications in a Cohort of Non-Referred Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

CD5+ Chronic B-Cell Lymphoproliferative Disorders Could Contain a Novel Disease Entity.

Email alerts

ASH Publications

American Society of Hematology

In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently From Rai Staging or Cytogenetics

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Infectious Complications Among Individuals with Monoclonal B-Cell Lymphocytosis (MBL): A Prospective Case-Control Study of Newly Diagnosed Patients,

The Prevalence of Serious Infectious Complications in a Cohort of Non-Referred Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Compared to Controls: Results of a Cohort Study

Alemtuzumab Use and Survival After Reduced Intensity Allogeneic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia (CLL),

CD5+ Chronic B-Cell Lymphoproliferative Disorders Could Contain a Novel Disease Entity.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only